SHSE:605033's ROE % is ranked worse than 58.73% of 252
companies
in the Agriculture industry
Industry Median: 6.61
vs SHSE:605033: 4.69
Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Shaanxi Meibang Pharmaceutical Group Co ROE % Related Terms
Shaanxi Meibang Pharmaceutical Group Co ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shaanxi Meibang Pharmaceutical Group Co ROE % Chart
Shaanxi Meibang Pharmaceutical Group Co Annual Data
For the Agricultural Inputs subindustry, Shaanxi Meibang Pharmaceutical Group Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shaanxi Meibang Pharmaceutical Group Co ROE % vs Agriculture Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) has a ROE % of 12.17% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Shaanxi Meibang Pharmaceutical Group Co and its competitors. This is 31% below median its historical median of 17.76. Over the past decade, Shaanxi Meibang Pharmaceutical Group Co's ROE % has ranged from 3.29 to 33.93. According to the industry distribution chart, Shaanxi Meibang Pharmaceutical Group Co ranks #148 out of 252 companies in the Agriculture industry, placing it in the top 58.7%.
Is Shaanxi Meibang Pharmaceutical Group Co's ROE % too high?
Shaanxi Meibang Pharmaceutical Group Co's current ROE % of 12.17% is 31% below median its 10-year median of 17.76. Over the past 10 years, this metric has ranged from a low of 3.29 to a high of 33.93. The Agriculture industry median ROE % is 6.61. Shaanxi Meibang Pharmaceutical Group Co's value of 12.17% is 84.1% above this industry median. Based on the distribution chart, Shaanxi Meibang Pharmaceutical Group Co ranks #148 out of 252 companies in the Agriculture industry, which is below the industry midpoint. Overall, Shaanxi Meibang Pharmaceutical Group Co has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shaanxi Meibang Pharmaceutical Group Co's ROE % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Shaanxi Meibang Pharmaceutical Group Co ranks #148 out of 252 companies for ROE %. This places Shaanxi Meibang Pharmaceutical Group Co in the lower half of its industry. The industry median ROE % is 6.61. Shaanxi Meibang Pharmaceutical Group Co's value of 12.17% is 84.1% above this benchmark. Historically, Shaanxi Meibang Pharmaceutical Group Co's own ROE % has ranged from 3.29 to 33.93 over the past decade. While the company's 10-year median is 17.76 vs. the industry median of 6.61, Shaanxi Meibang Pharmaceutical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Agriculture company?
The median ROE % among Agriculture companies is 6.61, based on 252 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shaanxi Meibang Pharmaceutical Group Co's current ROE % of 12.17% is 84.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Shaanxi Meibang Pharmaceutical Group Co and its competitors. For the Agriculture industry, the median ROE % is 6.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shaanxi Meibang Pharmaceutical Group Co's current ROE % is 12.17%, which is 31% below median its own 10-year median of 17.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shaanxi Meibang Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥22.13, compared to a current price of ¥17.37 — trading 21.5% below its estimated fair value. The current ROE % is 12.17%, which is 31% below median its 10-year median of 17.76 and 84.1% above the Agriculture industry median of 6.61. Shaanxi Meibang Pharmaceutical Group Co's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033), the current ROE % is 12.17% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) Overvalued in 2026?
Based on GuruFocus' analysis, Shaanxi Meibang Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of ¥17.37 is trading 21.5% below its estimated GF Value™ of ¥22.13.
GuruFocus considers Shaanxi Meibang Pharmaceutical Group Co to be Modestly Undervalued.
Key valuation signals for SHSE:605033:
ROE %: 12.17% (31% below median its 10-year median of 17.76)
GF Value™: ¥22.13 vs. price of ¥17.37 (21.5% below fair value)
Industry Position: 84.1% above the Agriculture median (#148 of 252)
No single metric tells the full story. See the SHSE:605033 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shaanxi Meibang Pharmaceutical Group Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:605033 has been successfully added to your 
